Stocks and Investing Stocks and Investing
Tue, July 18, 2023

Eun Yang Downgraded (BBIO) to Hold and Increased Target to $33 on, Jul 18th, 2023


Published on 2024-10-28 04:54:19 - WOPRAI, Eun Yang
  Print publication without navigation


Eun Yang of Jefferies, Downgraded "BridgeBio Pharma, Inc." (BBIO) to Hold and Increased Target from $24 to $33 on, Jul 18th, 2023.

Eun has made no other calls on BBIO in the last 4 months.



There are 3 other peers that have a rating on BBIO. Out of the 3 peers that are also analyzing BBIO, 0 agree with Eun's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Eun


  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $29 on, Monday, May 8th, 2023
  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $40 on, Wednesday, April 19th, 2023
  • Mani Foroohar of "SVB Securities" Maintained at Buy with Increased Target to $27 on, Thursday, April 13th, 2023

Contributing Sources